Literature DB >> 10754382

The FVII activating protease cleaves single-chain plasminogen activators.

J Römisch1, S Vermöhlen, A Feussner, H Stöhr.   

Abstract

A serine protease isolated from plasma sharing structural characteristics with a hepatocyte growth factor activator-like protease has been demonstrated recently to activate FVII. Accordingly, it was named 'FVII activator'. Until now an impact of this protease on the fibrinolytic system has not been reported. We islolated the protease from cryo-poor plasma by subsequent ion exchange chromatography and adsorption to immobilized heparin and/or aprotinin. Incubation of single-chain plasminogen activators (sc-PAs) with the FVII activator revealed significant activation of urokinase sc-PA (scu-PA) and tissue sc-PA (sct-PA) in vitro. It was enhanced in the presence of calcium and heparin. Compared to kallikrein, a more efficient activation of scu-PA was observed, whereas sct-PA appeared to be a poorer substrate for the FVI activator. At low protease concentrations and in the presence of heparin the scu-PA activation was comparable to plasmin. Employing recalcified whole blood thrombelastography, the lysis of initially formed fibrin was observed after addition of a combination of scu-PA and the FVII activator, whereas the scu-PA alone had a negligible effect at the concentration used. The study results as presented demonstrate that the FVII activator is a potent activator of sc-PAs in vitro. Whether it plays a physiological role in fibrinolysis deserves further investigation. Its comparatively high affinity to heparin assumes a function in cell surface or matrix events. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10754382     DOI: 10.1159/000022515

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  18 in total

1.  Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP).

Authors:  Fumie Nakazawa; Christian Kannemeier; Aya Shibamiya; Yutong Song; Eleni Tzima; Uwe Schubert; Takatoshi Koyama; Michael Niepmann; Heidi Trusheim; Bernd Engelmann; Klaus T Preissner
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

Review 2.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

3.  Whole-exome sequencing in evaluation of patients with venous thromboembolism.

Authors:  Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee
Journal:  Blood Adv       Date:  2017-06-29

4.  Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.

Authors:  Sandip M Kanse; Paul J Declerck; Wolfram Ruf; George Broze; Michael Etscheid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

5.  Role of glycine 221 in catalytic activity of hyaluronan-binding protein 2.

Authors:  Fabian Stavenuiter; Eduard H T M Ebberink; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2017-02-27       Impact factor: 5.157

6.  Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation.

Authors:  Aya Shibamiya; Lars Muhl; Susanne Tannert-Otto; Klaus T Preissner; Sandip M Kanse
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

7.  Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS).

Authors:  Malgorzata Wygrecka; Philipp Markart; Ludger Fink; Andreas Guenther; Klaus T Preissner
Journal:  Thorax       Date:  2007-05-04       Impact factor: 9.139

8.  Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.

Authors:  Sudheer Kumar Gara; Li Jia; Maria J Merino; Sunita K Agarwal; Lisa Zhang; Maggie Cam; Dhaval Patel; Electron Kebebew
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245

9.  Potent antitumor activity of a urokinase-activated engineered anthrax toxin.

Authors:  Shihui Liu; Hannah Aaronson; David J Mitola; Stephen H Leppla; Thomas H Bugge
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

10.  Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study.

Authors:  Mariana S Parahuleva; Sandip Kanse; Hans Hölschermann; Kirila Zheleva; Daniel Zandt; Michael Worsch; Behnoush Parviz; Norbert Güttler; Harald Tillmanns; Andreas Böning; Ali Erdogan
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.